896756008: Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug)

• SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...
• \Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Transferase inhibitor-containing product\Phosphotransferase inhibitor-containing product\Protein kinase inhibitor-containing product\Epidermal growth factor receptor antagonist antineoplastic agent\Trastuzumab emtansine-containing product\Trastuzumab emtansine-containing product in parenteral dose form\Trastuzumab emtansine only product in parenteral dose form\Trastuzumab emtansine 100 mg powder for solution for infusion and/or injection vial\Trastuzumab emtansine 100 mg powder for solution for infusion vial
• \Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Transferase inhibitor-containing product\Phosphotransferase inhibitor-containing product\Protein kinase inhibitor-containing product\Epidermal growth factor receptor antagonist antineoplastic agent\Trastuzumab emtansine-containing product\Trastuzumab emtansine only product\Trastuzumab emtansine only product in parenteral dose form\Trastuzumab emtansine 100 mg powder for solution for infusion and/or injection vial\Trastuzumab emtansine 100 mg powder for solution for infusion vial
• \Medicinal product categorised by disposition\Immunomodulator-containing product\Trastuzumab emtansine-containing product\Trastuzumab emtansine-containing product in parenteral dose form\Trastuzumab emtansine only product in parenteral dose form\Trastuzumab emtansine 100 mg powder for solution for infusion and/or injection vial\Trastuzumab emtansine 100 mg powder for solution for infusion vial
• \Medicinal product categorised by disposition\Immunomodulator-containing product\Trastuzumab emtansine-containing product\Trastuzumab emtansine only product\Trastuzumab emtansine only product in parenteral dose form\Trastuzumab emtansine 100 mg powder for solution for infusion and/or injection vial\Trastuzumab emtansine 100 mg powder for solution for infusion vial
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Polypeptide-containing product\Protein-containing product\Antibody-containing product\Monoclonal antibody-containing product\Monoclonal antibody antineoplastic agent\Trastuzumab emtansine-containing product\...
• \Trastuzumab emtansine-containing product in parenteral dose form\Trastuzumab emtansine only product in parenteral dose form\Trastuzumab emtansine 100 mg powder for solution for infusion and/or injection vial\Trastuzumab emtansine 100 mg powder for solution for infusion vial
• \Trastuzumab emtansine only product\Trastuzumab emtansine only product in parenteral dose form\Trastuzumab emtansine 100 mg powder for solution for infusion and/or injection vial\Trastuzumab emtansine 100 mg powder for solution for infusion vial
• \Medicinal product categorised by therapeutic role\Antineoplastic agent\...
• \Monoclonal antibody antineoplastic agent\Trastuzumab emtansine-containing product\...
• \Trastuzumab emtansine-containing product in parenteral dose form\Trastuzumab emtansine only product in parenteral dose form\Trastuzumab emtansine 100 mg powder for solution for infusion and/or injection vial\Trastuzumab emtansine 100 mg powder for solution for infusion vial
• \Trastuzumab emtansine only product\Trastuzumab emtansine only product in parenteral dose form\Trastuzumab emtansine 100 mg powder for solution for infusion and/or injection vial\Trastuzumab emtansine 100 mg powder for solution for infusion vial
• \Epidermal growth factor receptor antagonist antineoplastic agent\Trastuzumab emtansine-containing product\...
• \Trastuzumab emtansine-containing product in parenteral dose form\Trastuzumab emtansine only product in parenteral dose form\Trastuzumab emtansine 100 mg powder for solution for infusion and/or injection vial\Trastuzumab emtansine 100 mg powder for solution for infusion vial
• \Trastuzumab emtansine only product\Trastuzumab emtansine only product in parenteral dose form\Trastuzumab emtansine 100 mg powder for solution for infusion and/or injection vial\Trastuzumab emtansine 100 mg powder for solution for infusion vial
• \Product manufactured as parenteral dose form\Trastuzumab emtansine-containing product in parenteral dose form\Trastuzumab emtansine only product in parenteral dose form\Trastuzumab emtansine 100 mg powder for solution for infusion and/or injection vial\Trastuzumab emtansine 100 mg powder for solution for infusion vial

Status: current, Defined. Date: 31-Jan 2021. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
4029091014	Trastuzumab emtansine 100 mg powder for solution for infusion vial	en	Synonym	Active	Case insensitive	SNOMED CT core
4029092019	Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core

Expanded Value Set

Reference Sets

Description inactivation indicator reference set

Back to Start